A Thorough QTC Study to Assess the Effect of Cotadutide on Cardiac Repolarization in Healthy Participants

Inclusion Criteria: * Healthy male and female participants of age 18 to 55 years. * Females must have a negative pregnancy test. * Have a Body Mass Index (BMI) of ≥ 18 and ≤ 29.9 kg/m\^2. Exclusion Criteria: * History or presence of any clinically significant disease or disorder. * History or presence of gastrointestinal, hepatic or renal disease, or any other condition (including gastrointestinal surgery) known to interfere with absorption, distribution, metabolism, or excretion of drugs. * History of acute or chronic pancreatitis. * Family history of sudden cardiac death before the age of 50 of a first-degree relative. * History of additional risk factors for Torsade de Pointes (eg, heart failure, clinically important bradycardia and electrolyte disturbances eg, hypokalemia, hypocalcemia, hypomagnesemia or family history of long QT syndrome). * History of neoplastic disease * Any clinically significant abnormalities in clinical chemistry, hematology, urinalysis results or vital signs. * Any clinically significant abnormalities in rhythm, conduction, or morphology of the 12-lead resting electrocardiogram (ECG). * Any positive result on screening for serum hepatitis B surface antigen OR anti-HBc antibody, indicative of active hepatitis B (ie, participants with positive anti-HBc antibody result are acceptable if anti HBc IgM antibodies are negative), hepatitis C antibody, and Human immunodeficiency virus (HIV) antibody. * Current smokers or those who have smoked or used nic…